Robert Burns
Stock Analyst at H.C. Wainwright
Total Price Targets
33
Stocks Covered
18
Sectors
Healthcare
Most Recent
Apr 14, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Robert Burns
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | $169.00 | $140.52 | +20.3% | 2 | Apr 14, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $25.00 | $9.88 | +153.0% | 2 | Feb 24, 2026 |
| EXEL | Exelixis, Inc. | $52.00 | $43.81 | +18.7% | 5 | Jan 8, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $31.00 | $16.83 | +84.2% | 3 | Dec 10, 2025 |
| NUVB | Nuvation Bio Inc. | $10.00 | $4.50 | +122.5% | 3 | Dec 1, 2025 |
| ZYME | Zymeworks Inc. | $26.00 | $26.93 | -3.4% | 4 | Oct 14, 2025 |
| KPTI | Karyopharm Therapeutics Inc. | $15.00 | $8.77 | +71.1% | 1 | Oct 13, 2025 |
| BBOT | BridgeBio Oncology Therapeutics Inc. | $27.00 | $8.36 | +223.0% | 1 | Sep 15, 2025 |
| BCAX | Bicara Therapeutics Inc. Common Stock | $40.00 | $21.90 | +82.6% | 1 | Aug 22, 2025 |
| COGT | Cogent Biosciences, Inc. | $14.00 | $36.84 | -62.0% | 2 | Jan 14, 2025 |
| RLAY | Relay Therapeutics, Inc. | $19.00 | $12.90 | +47.2% | 1 | Sep 16, 2024 |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $36.00 | $30.55 | +17.8% | 2 | Sep 10, 2024 |
| IMMX | Immix Biopharma, Inc. | $7.00 | $9.35 | -25.1% | 1 | Jul 1, 2024 |
| REPL | Replimune Group, Inc. | $17.00 | $2.46 | +592.5% | 1 | Jun 7, 2024 |
| TNGX | Tango Therapeutics, Inc. | $13.00 | $20.95 | -37.9% | 1 | May 28, 2024 |
| BDTX | Black Diamond Therapeutics, Inc. | $11.00 | $2.60 | +323.9% | 1 | May 16, 2024 |
| ADCT | ADC Therapeutics S.A. | $8.00 | $3.82 | +109.4% | 1 | May 7, 2024 |
| CLDI | Calidi Biotherapeutics, Inc. | $2.00 | $0.22 | +812.4% | 1 | Mar 21, 2024 |
Recent Activity
- Apr 14, 2026— Set$169.00price target onRVMD(Revolution Medicines, Inc.)
- Feb 24, 2026— Set$25.00price target onORIC(ORIC Pharmaceuticals, Inc.)
- Jan 8, 2026— Set$52.00price target onEXEL(Exelixis, Inc.)
- Dec 10, 2025— Set$31.00price target onNRIX(Nurix Therapeutics, Inc.)
- Dec 1, 2025— Set$10.00price target onNUVB(Nuvation Bio Inc.)
- Nov 5, 2025— Set$49.00price target onEXEL(Exelixis, Inc.)
- Oct 14, 2025— Set$26.00price target onZYME(Zymeworks Inc.)
- Oct 13, 2025— Set$15.00price target onKPTI(Karyopharm Therapeutics Inc.)
- Sep 15, 2025— Set$27.00price target onBBOT(BridgeBio Oncology Therapeutics Inc.)
- Aug 22, 2025— Set$40.00price target onBCAX(Bicara Therapeutics Inc. Common Stock)
- Aug 12, 2025— Set$46.00price target onEXEL(Exelixis, Inc.)
- May 14, 2025— Set$72.00price target onRVMD(Revolution Medicines, Inc.)
- Jan 14, 2025— Set$14.00price target onCOGT(Cogent Biosciences, Inc.)
- Jan 10, 2025— Set$40.00price target onEXEL(Exelixis, Inc.)
- Oct 21, 2024— Set$30.00price target onNRIX(Nurix Therapeutics, Inc.)
- Sep 25, 2024— Set$12.00price target onZYME(Zymeworks Inc.)
- Sep 16, 2024— Set$7.00price target onNUVB(Nuvation Bio Inc.)
- Sep 16, 2024— Set$19.00price target onRLAY(Relay Therapeutics, Inc.)
- Sep 10, 2024— Set$36.00price target onAVBP(ArriVent BioPharma, Inc. Common Stock)
- Sep 3, 2024— Set$17.00price target onCOGT(Cogent Biosciences, Inc.)
Frequently Asked Questions
Who is Robert Burns?
Robert Burns is a stock analyst at H.C. Wainwright covering 18 stocks primarily in Healthcare. They have issued 33 price targets since Sep 20, 2021.
What stocks does Robert Burns cover?
Robert Burns currently covers 18 stocks, including EXEL, ZYME, NRIX, NUVB, RVMD.
What is Robert Burns's latest price target?
Robert Burns's most recent price target was $169.00 on RVMD (Revolution Medicines, Inc.), set on Apr 14, 2026.
What is Robert Burns's highest price target?
Robert Burns's highest issued price target is $169.00 on RVMD, set on Apr 14, 2026.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.